The Drug Topics BPA Statement
Study: CGMs Show Promise in Early Diagnostic of Type 2 Diabetes
This method supports improved, early detection for diabetes without relying on blood samples or complex procedures.
How LucyRx is Changing the Traditional PBM Model
LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.
As a Result of PBM Reform, CVS Will Close Over 20 Pharmacies in Arkansas
CVS releases a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from owning pharmacies.
The Rise in Direct-to-Consumer Advertising of Prescription Drugs
Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.
ADA Updates Diabetes Treatment Guidelines to Reelect Benefits of GLP-1
Further, the authors of the “Standards of Care in Diabetes 2025” highlighted the benefits of continuous glucose monitoring systems and recommend initiating these as soon as possible.
PCV13 Significantly Reduces Invasive Pneumococcal Disease in Pediatric Patients
Researchers explore trends from 2014 to 2022 among pediatric invasive pneumococcal diseases since introduction of the 13-valent pneumococcal conjugate vaccine.
